Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001542 · ClinicalTrials.gov registry record · Phase 4
Fluconazole Prophylaxis of Thrush in AIDS
A Phase 4 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT00001542 is a Phase 4 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 80 participants.
The verdict
NCT00001542, a Phase 4 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a placebo-controlled trial of intermittent fluconazole prophylaxis (200 mg orally three times a week) in the prevention of thrush.
Interventions
- DRUG fluconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 1996-07 |
| Est. Completion | 2001-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001542
The ClinicalTrials.gov registry entry for NCT00001542 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluconazole is the first listed.
NCT00001542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001542 about?
NCT00001542 is a clinical study titled "Fluconazole Prophylaxis of Thrush in AIDS". This is a placebo-controlled trial of intermittent fluconazole prophylaxis (200 mg orally three times a week) in the prevention of thrush.
What is the current status of trial NCT00001542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 1996-07. Estimated completion is 2001-11.
What interventions are being tested in trial NCT00001542?
The interventions under investigation include: fluconazole (DRUG).
Who is sponsoring clinical trial NCT00001542?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.